BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20348421)

  • 21. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
    Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis.
    Elsawa SF; Bost KL
    J Immunol; 2004 Jan; 172(1):516-24. PubMed ID: 14688362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
    Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
    Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of effector memory TCR Vbeta4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance.
    Stapler D; Lee ED; Selvaraj SA; Evans AG; Kean LS; Speck SH; Larsen CP; Gangappa S
    J Immunol; 2008 Mar; 180(5):3190-200. PubMed ID: 18292543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
    Jennings RN; Grayson JM; Barton ES
    J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
    Li JM; Southerland L; Hossain MS; Giver CR; Wang Y; Darlak K; Harris W; Waschek J; Waller EK
    J Immunol; 2011 Jul; 187(2):1057-65. PubMed ID: 21677142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Human STAT1 Gain-of-Function Mutation Impairs CD8
    Qian W; Miner CA; Ingle H; Platt DJ; Baldridge MT; Miner JJ
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.
    Huss DJ; Winger RC; Peng H; Yang Y; Racke MK; Lovett-Racke AE
    J Immunol; 2010 May; 184(10):5628-36. PubMed ID: 20393141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 expression is upregulated by DNA hypomethylation after hematopoietic stem cell transplantation.
    Domingo-Gonzalez R; Huang SK; Laouar Y; Wilke CA; Moore BB
    J Immunol; 2012 Nov; 189(9):4528-36. PubMed ID: 23008450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice.
    Panoskaltsis-Mortari A; Hermanson JR; Taras E; Wangensteen OD; Serody JS; Blazar BR
    Blood; 2003 May; 101(9):3714-21. PubMed ID: 12511416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathology.
    Gurczynski SJ; Pereira NL; Hrycaj SM; Wilke C; Zemans RL; Moore BB
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.
    Nakamura K; Kitani A; Fuss I; Pedersen A; Harada N; Nawata H; Strober W
    J Immunol; 2004 Jan; 172(2):834-42. PubMed ID: 14707053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.
    Zhang W; Zhang D; Shen M; Liu Y; Tian Y; Thomson AW; Lee WP; Zheng XX
    J Immunol; 2010 Oct; 185(8):4750-9. PubMed ID: 20844194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
    Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
    J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
    Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.